| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Metacrine, Inc. | Director | Stock Option (right to buy) | 16,500 | 18 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122048887-jonker-jeffrey-david-2022-05-18 | Metacrine, Inc. | 18 May 2022 | 1 | $0 | 4 | Director | 06 Sep 2022, 19:26 |
| /report/000120919121035783-jonker-jeffrey-david-2021-05-24 | Metacrine, Inc. | 24 May 2021 | 1 | $0 | 4 | Director | 25 May 2021, 18:59 |